Related Experiment Videos
Rofecoxib-associated upper gastrointestinal bleed: a case report
Gordon M Freedman1, Joel M Kreitzer, Ruchi Badola
1Pain Management Service, Box 1192, Mount Sinai School of Medicine, One East 100th Street, New York, NY 10029, USA.
The Mount Sinai Journal of Medicine, New York
|February 8, 2002
Abstract:
To our knowledge, this is the first clinical report of a rofecoxib-associated upper gastrointestinal hemorrhage. We urge caution in prescribing rofecoxib to patients with risk factors for peptic ulcer disease and recommend limiting the dose to 25 mg per day for these patients.